openPR Logo
Press release

Conjunctivitis Treatment Market Competitive Landscape By Nicox, Eyevance Pharmaceuticals LLC, ALLERGAN, Novartis AG, Aurobindo Pharma, Cipla Inc

09-25-2020 08:56 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Conjunctivitis Treatment Market

Conjunctivitis Treatment Market

Conjunctivitis Treatment Market is rising gradually with a substantial CAGR in the forecast period of 2019-2026. Growing population of stye population worldwide and emergence of drugs used in the treatment of risk associated with stye disease are the key factors to drive the market growth. Global Conjunctivitis Treatment Market By Type (Allergic Conjunctivitis, Infectious Conjunctivitis, Chemical Conjunctivitis), Therapy Type (Antibiotic Therapy and Eye Warming Therapy), Drugs (Antibiotics, Ophthalmic Steroids, Non-Steroidal Anti-Inflammatory Drugs, Antihistamines and Others),  Route of Administration (Oral and Topical),  End- users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026

Few of the major competitors currently working in the global conjunctivitis treatment market are Nicox, Eyevance Pharmaceuticals LLC, ALLERGAN, Novartis AG, Aurobindo Pharma, Cipla Inc, Mylan .N.V, WOCKHARDT, Akron Incorporated, USV Private Limited, Bausch Health, Teva Pharmaceutical Industries Ltd, LUPIN, Dr. Reddy’s Laboratories Ltd, Mankind Pharma, Micro Labs Ltd and many others.

Download Sample Copy of Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-conjunctivitis-treatment-market

Market Drivers

Ongoing clinical trial studies being carried out by many pharmaceuticals industries
Exposure to certain toxin or change in environment may increase the stye infections
Prevalence of indoor as well as outdoor allergens.
Increase in prevalence rate of stye disease worldwide

Market Restraints

Effective treatment is either unavailable or unaffordable.
Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market.
Inadequate knowledge about stye disease in some developing countries

Segmentation: Global conjunctivitis Treatment Market

By Type

Allergic Conjunctivitis
Infectious Conjunctivitis
Chemical Conjunctivitis

By Therapy Type

Antibiotics Therapy
Eyes Warming Therapy

By Drug Class

Antibiotics
Gatifloxacin
Moxifloxacin
Tobramycin
Others
Ophthalmic Steroids
Dexamethasone
Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
Diclofenac
Antihistamines
Lodoxamide
Olopatadine hydrochloride
Cetirizine
Others

By Route of administration

Oral
Topical

By End users

Hospitals
Homecare
Specialty Clinics
Others

By Geography

North America
US.
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Turkey
Belgium
Netherlands
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
South Korea
India
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Rest of Asia Pacific
Middle East & Africa
South Africa
Egypt
Saudi Arabia
United Arab Emirates
Israel
Rest of Middle East & Africa

Key Developments in the Market:

In December 2018, Alembic Pharmaceuticals Limited received an abbreviated New Drug application approval from the FDA for olopatadine hydrochloride, selective H1-receptor antagonist for the treatment of allergic conjunctivitis. The approval of olopatadine hydrochloride strengthens the company’s generic portfolio as well as improves the treatment paradigms for parients suffering from allergic conjunctivitis.

In June 2017, Nicox received an approval from the FDA for Zerviate (cetirizine ophthalmic solution) 0.24% for the treatment of ocular itching associated with allergic conjunctivitis. The approval of Zerviate marks an important commercial milestone to bring first topical ocular formulation of cetirizine, a second generation antihistamine and improve the millions of people sufferinf from conjunctivitis.

Competitive Analysis:

Global conjunctivitis treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global conjunctivitis treatment market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

Current and future global conjunctivitis treatment market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period

View Full TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-conjunctivitis-treatment-market

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Conjunctivitis Treatment Market Competitive Landscape By Nicox, Eyevance Pharmaceuticals LLC, ALLERGAN, Novartis AG, Aurobindo Pharma, Cipla Inc here

News-ID: 2143360 • Views:

More Releases from Data Bridge Market Research

Exploring the Aircraft Hangar Market: Key Trends and Growth Drivers
Exploring the Aircraft Hangar Market: Key Trends and Growth Drivers
The aircraft hangar market plays a crucial role in the aviation industry, providing essential storage and maintenance facilities for aircraft. With the rise in global air travel and advancements in aviation technology, the demand for sophisticated and strategically located hangars is on the rise. This post provides a comprehensive overview of the aircraft hangar market, outlining its scope, current trends, and the factors driving its growth. Data Bridge Market Research analyzes
Understanding the Tennis Racquet Market: Trends and Drivers
Understanding the Tennis Racquet Market: Trends and Drivers
The tennis racquet market is a dynamic and evolving segment within the broader sports equipment industry. With a focus on enhancing player performance and accommodating diverse playing styles, this market has experienced significant growth and transformation over the years. This guest post provides an overview of the tennis racquet market, its scope, current trends, and the factors driving its growth. Data Bridge Market Research analyses that the tennis racquet market was
Understanding the Application Processor Market: Trends, Scope, and Growth Drivers
Understanding the Application Processor Market: Trends, Scope, and Growth Driver …
In the ever-evolving landscape of technology, application processors stand as critical components powering a wide array of electronic devices. From smartphones and tablets to wearables and automotive systems, these processors are the brains behind the seamless performance and functionalities we rely on daily. This guest post delves into the application processor market, offering an overview, exploring its scope, examining current trends, and identifying key factors driving its growth. The application processor
Neuromorphic Computing: Revolutionizing the Future of Technology
Neuromorphic Computing: Revolutionizing the Future of Technology
Neuromorphic computing is an advanced area of research and development that mimics the way the human brain operates. Unlike traditional computing systems that process information in a linear and sequential manner, neuromorphic systems are designed to emulate the brain's neural architecture. This approach allows for parallel processing, greater efficiency, and the potential to solve complex tasks more efficiently than conventional computers. Neuromorphic computing relies on specialized hardware and algorithms that

All 5 Releases


More Releases for Conjunctivitis

Conjunctivitis Market - key players covered:Pfizer, Inc., Novartis, ... Conjunct …
Los Angeles, United State, –The report titled Global Conjunctivitis Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Conjunctivitis market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Conjunctivitis market.
Acute Conjunctivitis Treatment Market | Bacterial conjunctivitis | PBIGP
The Future Insights Of Global Acute Conjunctivitis Treatment Market Conjunctivitis, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Conjunctivitis can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but treatment can
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but
Viral Conjunctivitis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Viral Conjunctivitis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Viral Conjunctivitis - Pipeline Review, H2 2017, provides an overview of the Viral Conjunctivitis (Ophthalmology) pipeline landscape. Viral conjunctivitis, or pinkeye, is a common, self-limiting condition that is typically caused by adenovirus. Viral conjunctivitis is highly
Allergic Conjunctivitis - Pipeline Review, H2 2016
MarketResearchReports.Biz presents this most up-to-date research on "Allergic Conjunctivitis - Pipeline Review, H2 2016" Description Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Allergic Conjunctivitis Pipeline Review, H2 2016, provides an overview of the Allergic Conjunctivitis (Ophthalmology) pipeline landscape. Allergic conjunctivitis occurs when the clear layer of tissue lining the eyelids and covering the white of the eye (conjunctiva) become swollen or inflamed due to a reaction to pollen, dander, mold,